| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | -27.9% | +18.2% |
| Cost of Revenue | $3.5M | -15.3% | +14.0% |
| Gross Profit | -$45K | -106.9% | +68.9% |
| R&D Expense | $89K | — | +0.0% |
| SG&A Expense | $651K | +7.5% | -14.9% |
| Operating Income | -$2.8M | -65.7% | +7.1% |
| Net Income | -$2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $2.5M | -8.2% | -26.4% |
| Current Assets | $10.1M | -24.9% | -34.6% |
| Total Assets | $18.9M | -15.5% | -37.3% |
| Current Liabilities | $2.4M | -23.9% | -36.6% |
| Long-term Debt | $500K | +0.0% | +0.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | — | — |
| Capital Expenditures | $2.0M | — | — |
| Investing Cash Flow | -$2.0M | — | — |
| Financing Cash Flow | $2.3M | — | — |
| Free Cash Flow | -$7.1M | — | — |
| -9.7% |
| EPS (Basic) | -$1.23 | -41.4% | -373.1% |
| EPS (Diluted) | -$1.23 | -41.4% | -373.1% |
| $3.0M |
| -20.7% |
| -57.3% |
| Stockholders' Equity | $15.9M | -14.5% | -8.4% |